Clinical Trial

PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)

Study acronym: PIONEER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational, prospective, multi-center trial designed to evaluate clinical outcomes in kidney transplant recipients undergoing TruGraf and TRAC monitoring. Approximately 15 U.S. sites
Trial Details
NCT Number NCT07231328
Lead Sponsor Transplant Genomics, Inc.
Collaborators: Medical University of South Carolina, Northwestern University, The Cleveland Clinic, University of Washington, University of California, Los Angeles, University of Nebraska, Duke University, University of Utah, Georgetown University, Virginia Commonwealth University, The Methodist Hospital Research Institute, Keck School of Medicine USC, Weill Medical College of Cornell University, Erie County Medical Center, East Carolina University, AdventHealth
Conditions Immunosuppression Management, Biomarkers / Blood, Subclinical Rejection, Biopsy, Kidney Transplant Rejection
Enrollment 600 participants
Start Date 2025-11-20
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-17